These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18193641)

  • 21. Functional studies of RYR1 mutations in the skeletal muscle ryanodine receptor using human RYR1 complementary DNA.
    Sato K; Pollock N; Stowell KM
    Anesthesiology; 2010 Jun; 112(6):1350-4. PubMed ID: 20461000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central core disease and susceptibility to malignant hyperthermia in a single family.
    Colleoni L; Melli G; Morandi L; Cudia P; Romaggi S; Mantegazza R; Bernasconi P
    J Neurol; 2009 Jul; 256(7):1161-3. PubMed ID: 19252784
    [No Abstract]   [Full Text] [Related]  

  • 23. Additional evidence that the ryanodine receptor gene (RYR1) causes malignant hyperthermia and severe skeletal malformations.
    Kakisaka Y; Haginoya K; Takahashi Y; Ochiai T; Fujiwara I; Kikuchi A; Wakusawa K; Kobayashi S; Kikuchi H; Ichihara Y; Takahashi S; Nishino I
    Am J Med Genet A; 2013 Jan; 161A(1):234-5. PubMed ID: 23239586
    [No Abstract]   [Full Text] [Related]  

  • 24. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
    Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
    Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease.
    Vukcevic M; Broman M; Islander G; Bodelsson M; Ranklev-Twetman E; Müller CR; Treves S
    Anesth Analg; 2010 Jul; 111(1):185-90. PubMed ID: 20142353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arrhythmogenic mutation-linked defects in ryanodine receptor autoregulation reveal a novel mechanism of Ca2+ release channel dysfunction.
    George CH; Jundi H; Walters N; Thomas NL; West RR; Lai FA
    Circ Res; 2006 Jan; 98(1):88-97. PubMed ID: 16339485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel regulators of RyR Ca2+ release channels: insight into molecular changes in genetically-linked myopathies.
    Dulhunty AF; Beard NA; Pouliquin P; Kimura T
    J Muscle Res Cell Motil; 2006; 27(5-7):351-65. PubMed ID: 16909197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
    Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
    Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Ile2453Thr mutation in the ryanodine receptor gene 1 is associated with facilitated calcium release from sarcoplasmic reticulum by 4-chloro-m-cresol in human myotubes.
    Wehner M; Rueffert H; Koenig F; Meinecke CD; Olthoff D
    Cell Calcium; 2003 Aug; 34(2):163-8. PubMed ID: 12810058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skeletal muscle ryanodine receptor mutations associated with malignant hyperthermia showed enhanced intensity and sensitivity to triggering drugs when expressed in human embryonic kidney cells.
    Sato K; Roesl C; Pollock N; Stowell KM
    Anesthesiology; 2013 Jul; 119(1):111-8. PubMed ID: 23459219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiminicore myopathy, central core disease, malignant hyperthermia susceptibility, and RYR1 mutations: one disease with many faces?
    Mathews KD; Moore SA
    Arch Neurol; 2004 Jan; 61(1):27-9. PubMed ID: 14732615
    [No Abstract]   [Full Text] [Related]  

  • 32. Intracellular Ca2+ dynamics in malignant hyperthermia and central core disease: established concepts, new cellular mechanisms involved.
    Avila G
    Cell Calcium; 2005 Feb; 37(2):121-7. PubMed ID: 15589992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia.
    Marks AR; Priori S; Memmi M; Kontula K; Laitinen PJ
    J Cell Physiol; 2002 Jan; 190(1):1-6. PubMed ID: 11807805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
    Ta TA; Pessah IN
    Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing.
    Ibarra M CA; Wu S; Murayama K; Minami N; Ichihara Y; Kikuchi H; Noguchi S; Hayashi YK; Ochiai R; Nishino I
    Anesthesiology; 2006 Jun; 104(6):1146-54. PubMed ID: 16732084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arrhythmogenic mechanisms in ryanodine receptor channelopathies.
    Zhao YT; Valdivia CR; Gurrola GB; Hernández JJ; Valdivia HH
    Sci China Life Sci; 2015 Jan; 58(1):54-8. PubMed ID: 25480325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of a family with the skeletal muscle RYR1 mutation (c.7354C>T) associated with central core myopathy and malignant hyperthermia susceptibility.
    Taylor A; Lachlan K; Manners RM; Lotery AJ
    J Clin Neurosci; 2012 Jan; 19(1):65-70. PubMed ID: 22030266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominant and recessive RYR1 mutations in adults with core lesions and mild muscle symptoms.
    Duarte ST; Oliveira J; Santos R; Pereira P; Barroso C; Conceição I; Evangelista T
    Muscle Nerve; 2011 Jul; 44(1):102-8. PubMed ID: 21674524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered function and regulation of cardiac ryanodine receptors in cardiac disease.
    Wehrens XH; Marks AR
    Trends Biochem Sci; 2003 Dec; 28(12):671-8. PubMed ID: 14659699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two central core disease (CCD) deletions in the C-terminal region of RYR1 alter muscle excitation-contraction (EC) coupling by distinct mechanisms.
    Lyfenko AD; Ducreux S; Wang Y; Xu L; Zorzato F; Ferreiro A; Meissner G; Treves S; Dirksen RT
    Hum Mutat; 2007 Jan; 28(1):61-8. PubMed ID: 16958053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.